BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16415157)

  • 1. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.
    Smith LT; Lin M; Brena RM; Lang JC; Schuller DE; Otterson GA; Morrison CD; Smiraglia DJ; Plass C
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):982-7. PubMed ID: 16415157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.
    Arab K; Smith LT; Gast A; Weichenhan D; Huang JP; Claus R; Hielscher T; Espinosa AV; Ringel MD; Morrison CD; Schadendorf D; Kumar R; Plass C
    Carcinogenesis; 2011 Oct; 32(10):1467-73. PubMed ID: 21771727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.
    Tessema M; Willink R; Do K; Yu YY; Yu W; Machida EO; Brock M; Van Neste L; Stidley CA; Baylin SB; Belinsky SA
    Cancer Res; 2008 Mar; 68(6):1707-14. PubMed ID: 18339850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
    Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
    Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
    Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF
    Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.
    Weiss D; Stockmann C; Schrödter K; Rudack C
    Cell Oncol (Dordr); 2013 Jun; 36(3):213-24. PubMed ID: 23529585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers.
    Richards KL; Zhang B; Sun M; Dong W; Churchill J; Bachinski LL; Wilson CD; Baggerly KA; Yin G; Hayes DN; Wistuba II; Krahe R
    Cancer; 2011 Feb; 117(3):606-17. PubMed ID: 20945327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis.
    Takai D; Yagi Y; Wakazono K; Ohishi N; Morita Y; Sugimura T; Ushijima T
    Oncogene; 2001 Nov; 20(51):7505-13. PubMed ID: 11709722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay.
    Shivapurkar N; Stastny V; Xie Y; Prinsen C; Frenkel E; Czerniak B; Thunnissen FB; Minna JD; Gazdar AF
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):995-1000. PubMed ID: 18398044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer.
    Kim M; Kim JH; Jang HR; Kim HM; Lee CW; Noh SM; Song KS; Cho JS; Jeong HY; Hahn Y; Yeom YI; Yoo HS; Kim YS
    Cancer Res; 2008 Sep; 68(17):7147-55. PubMed ID: 18757430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
    Oh JJ; Boctor BN; Jimenez CA; Lopez R; Koegel AK; Taschereau EO; Phan DT; Jacobsen SE; Slamon DJ
    Hum Genet; 2008 Feb; 123(1):55-64. PubMed ID: 18038152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.